Хайлтын үр дүнгүүд - Corey Cutler
- 181-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
How we treat higher-risk myelodysplastic syndromes -н Mikkael A. Sekeres, Corey Cutler
Хэвлэсэн 2013Artigo -
3
-
4
-
5
B Cells in Chronic Graft-versus-Host Disease -н Stefanie Sarantopoulos, Bruce R. Blazar, Corey Cutler, Jerome Ritz
Хэвлэсэн 2014Revisão -
6
-
7
-
8
-
9
Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation -н Corey Cutler, Shuli Li, Vincent T. Ho, John Koreth, Edwin P. Alyea, Robert J. Soiffer, Joseph H. Antin
Хэвлэсэн 2006Artigo -
10
Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy -н Akiko Saito, David Zahrieh, Corey Cutler, Vincent T. Ho, Joseph H. Antin, Robert J. Soiffer, Edwin P. Alyea, S J Lee
Хэвлэсэн 2007Artigo -
11
-
12
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation -н Philippe Armand, Haesook T. Kim, Corey Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Robert J. Soiffer, Joseph H. Antin
Хэвлэсэн 2007Artigo -
13
Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials -н Zachariah DeFilipp, Haesook T. Kim, Zhongming Yang, John T. Noonan, Bruce R. Blazar, Stephanie J. Lee, Steven Z. Pavletic, Corey Cutler
Хэвлэсэн 2022Artigo -
14
Outcome and Prognostic Factors for Patients Who Relapse after Allogeneic Hematopoietic Stem Cell Transplantation -н Gita Thanarajasingam, Haesook T. Kim, Corey Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer, Philippe Armand
Хэвлэсэн 2013Artigo -
15
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease Prophylaxis after Reduced-Inte... -н Vincent T. Ho, Julie Aldridge, Haesook T. Kim, Corey Cutler, John Koreth, Philippe Armand, Joseph H. Antin, Robert J. Soiffer, Edwin P. Alyea
Хэвлэсэн 2009Artigo -
16
-
17
Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post–allogeneic HCT -н Mohammad Abu Zaid, Juan Wu, Cindy Wu, Brent R. Logan, Jeffrey Yu, Corey Cutler, Joseph H. Antin, Sophie Paczesny, Sung Won Choi
Хэвлэсэн 2016Artigo -
18
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation -н Vincent T. Ho, Corey Cutler, Shelly Carter, Paul J. Martin, Roberta Adams, Mary M. Horowitz, James L.M. Ferrara, Robert J. Soiffer, Sergio Giralt
Хэвлэсэн 2005Revisão -
19
Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age -н John Koreth, Julie Aldridge, Haesook T. Kim, Edwin P. Alyea, Corey Cutler, Philippe Armand, Jerome Ritz, Joseph H. Antin, Robert J. Soiffer, Vincent T. Ho
Хэвлэсэн 2010Artigo -
20
Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS) -н Wael Saber, Corey Cutler, Ryotaro Nakamura, Mei-Jie Zhang, Ehab Atallah, J. Douglas Rizzo, Richard T. Maziarz, Jorge E. Cortés, Matt Kalaycio, Mary M. Horowitz
Хэвлэсэн 2013Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Transplantation
Hematopoietic stem cell transplantation
Immunology
Graft-versus-host disease
Gastroenterology
Biology
Oncology
Surgery
Disease
Genetics
Stem cell
Bone marrow
Confidence interval
Immune system
Chemotherapy
Haematopoiesis
Myelodysplastic syndromes
Leukemia
Cyclophosphamide
Cohort
Cumulative incidence
Clinical trial
Hazard ratio
Intensive care medicine
Physics
Cancer research
Hematopoietic cell
Myeloid leukemia